Episode Details

Back to Episodes
Episode 60: Cora Sternberg discusses AMG 160 - a bispecific antibody in prostate cancer

Episode 60: Cora Sternberg discusses AMG 160 - a bispecific antibody in prostate cancer

Season 1 Episode 60 Published 6 years, 1 month ago
Description

AMG 160; a half-life extended (HLE) bispecific T-cell engager (BITE®) antibody construct is discussed as is the future of immune therapy in CRPC. 

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us